Newer type 2 diabetes medications have heart and kidney disease benefits, too
Two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease. ...
Sep 28, 2020
0
11